Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Go back to Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
(NASDAQ: CLNN) Delayed: 3.88 +0.12 (3.19%)
Previous Close $3.76    52 Week High $ 
Open $3.73    52 Week Low $ 
Day High $4.01    P/E N/A 
Day Low $3.63    EPS $ 
Volume 124,246